National immunohistochemistry standardization program - establishment & launch - the overarching goal of this project is to change laboratory practice in the clinical immunohistochemistry (IHC)…

Ended Project Grant Awarded Last action

Award ID
R44CA268484
Recipient
Awarding agency
Obligated
$1,999,519

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Description

National immunohistochemistry standardization program - establishment & launch - the overarching goal of this project is to change laboratory practice in the clinical immunohistochemistry (IHC) laboratory. IHC is the only clinical laboratory discipline without reference standards and traceable units of measure. This is despite the fact IHC is a major testing format in surgical pathology; a typical hospital IHC lab has a test menu of approximately 200 different tests. As a result, IHC analytic error rates range from 10 - 30% as compared to…

Transactions

Action Obligated Date
Amendment $0
Amendment $898,163
Original award $1,101,356

Quick answers

Who received award R44CA268484?

R44CA268484 was awarded to Boston Cell Standards Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2021.

How much is award R44CA268484 worth?

$1,999,519 has been obligated on R44CA268484.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award